MAPT and Alzheimer disease: Haney et al. reported that the AD high-risk genotype APOE4/4 promotes lipid droplet accumulation in microglia via ACSL1 mediation, leading to Tau phosphorylation and neurotoxicity, highlighting lipid metabolic dysregulation as a key mechanism in AD pathogenesis [55].